Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update states that the study of Davunetide for Progressive Supranuclear Palsy has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• Davunetide (davunetide)

Snippet

Sponsor: Allon Therapeutics | Conditions: Progressive Supranuclear Palsy | Phase 2, Phase 3 | Status: COMPLETED